Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome


Autoria(s): Maurer, Michaela; Burri, Sonja; de Marchi, Stefano; Hullin, Roger; Martinelli, Michele; Mohacsi, Paul; Hess, Otto M.
Data(s)

2010

Resumo

Plasma homocysteine (Hcy) has been associated with an increased cardiovascular (CV) risk in patients with chronic heart failure (CHF). Thus, we investigated whether Hcy has a prognostic impact on CV events in CHF-patients with and without cardiorenal syndrome (CRS).

Formato

application/pdf

Identificador

http://boris.unibe.ch/34/1/34.pdf

Maurer, Michaela; Burri, Sonja; de Marchi, Stefano; Hullin, Roger; Martinelli, Michele; Mohacsi, Paul; Hess, Otto M. (2010). Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome. International journal of cardiology, 141(1), pp. 32-38. Amsterdam: Elsevier 10.1016/j.ijcard.2008.11.131 <http://dx.doi.org/10.1016/j.ijcard.2008.11.131>

doi:10.7892/boris.34

info:doi:10.1016/j.ijcard.2008.11.131

info:pmid:19181408

urn:issn:0167-5273

Idioma(s)

eng

Publicador

Elsevier

Relação

http://boris.unibe.ch/34/

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Maurer, Michaela; Burri, Sonja; de Marchi, Stefano; Hullin, Roger; Martinelli, Michele; Mohacsi, Paul; Hess, Otto M. (2010). Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome. International journal of cardiology, 141(1), pp. 32-38. Amsterdam: Elsevier 10.1016/j.ijcard.2008.11.131 <http://dx.doi.org/10.1016/j.ijcard.2008.11.131>

Palavras-Chave #610 Medicine & health
Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/publishedVersion

PeerReviewed